If we consider that around one in eight Americans have already tried a GLP-1 drug, according to healthy policy organisation KFF, and that more than two in five adults in the US live with obesity, there is real opportunity for pharma companies to meet this demand
is proud to be named one of The Minnesota Star Tribune's 2026 Top Workplaces
A clinical trial of people with alcohol use disorder who were taking semaglutide didnt find any adverse reactions between the two substances
Newborn screening for G6PD deficiency is not performed routinely in the United States, although it is done in countries with high disease prevalence
Storage Mounjaro: Refrigerate (2-8C) before first use
PlexusDx supports patients through these real-world health events with clear guidance, affordable access, and personalized protocols designed for long-term success